About
Our Core Values
At Guard Medical, we create products that can help deliver a better quality of life for surgical patients. NPseal is a simple, easy-to-use device that delivers Negative Pressure Wound Therapy (NPWT) and may promote wound healing while lowering the barriers of high complexity and cost. Numerous peer reviewed studies have demonstrated the utility of NPWT in reducing the risk of surgical site complications. *
We believe that all patients deserve smarter healing. By offering products that are easy-to-use and cost-effective, patients can receive well-known therapies that may promote healing.
At Guard Medical, we know great solutions don’t need to be complicated. We obsess over creating simple and effective NPWT products that are easy for clinicians and patients to use.
At Guard Medical, we understand that many patients who could benefit from negative pressure wound therapy aren’t offered it due to cost. We’re looking to dramatically change the cost of this therapy to allow more patients to benefit from smarter healing.
Elevate Patient Experience
At Guard Medical, we create products that can help deliver a better quality of life for surgical patients. We do this by focusing on solutions that may promote wound healing for happy patients and doctors.
Take a look
At our Twitter Feed
Guard Medical In The Media
Meet Our Team
Machiel van der Leest
Dr. Frederick Cornhill
Laurence Lefebvre
Gene Paik
Vice President of Sales & Marketing
Gene has over 20 years of strategic leadership experience primarily in the healthcare arena. His career spans across a multitude of medical specialties and medical device organizations both large and small, including Medtronic. Gene has worked extensively in the sales and delivery of medical product and training solutions, partnering with globally recognized thought leaders and surgical societies. He holds MS degrees from Rosalind Franklin University/Chicago Medical School and a BA from University of California at Berkeley.
Sang Lee, MD
Meet Our Board of Directors
Philippe Boucheron
Philippe has over twenty years of life science investment experience. He is a Deputy Chief of Life Sciences Investment at Bpifrance and serves on boards of Ademtech, GamaMabs, Advicenne, NH TherAguix, Limflow and Corwave. He holds an MBA from INSEAD.
Philippe Dhamelincourt
Philippe is co-founder and Chairman of Matignon Investissement & Gestion. Philippe has been active in venture capital investment for nearly 40 years. After Arthur Andersen and SIMER, Philippe joined the Worms Bank in 1978 and became CEO of ACMER.
Phil Cooper
Phil has more than 30 years of experience in the medical device industry. Phil was President of Molnlycke Wound Care from 2007 to 2014 Phil is a non-executive director for listed LiDCO Group PLC, Alesi Surgical Limited and Soest Medical Group (NLD).
Thierry Sarda
Thierry has over 25 years of experience in the medical device industry in sales, marketing and general management. Thierry designed and lead major transformation programs in various healthcare sectors from hospital to homecare, in France and Europe.
Meet Our Partners
Interested in Making An Impact?
* Strugala et al, Meta-Analysis of Comparative Trials Evaluating a Prophylactic Single-Use Negative Pressure Wound Therapy System for the Prevention of Surgical Site Complications, SURGICAL INFECTIONS Volume 18, Number 7, 2017
Hyldig, et al, Meta-analysis of negative-pressure wound therapy for closed surgical incisions, John Wiley &Sons on behalf of BJS Society, Ltd, 2016, 103; 477-486
Indications For Use per K212971
